Javier Cote-Sierra
Founder at Allianthera Suzhou Biopharmaceutical Co Ltd
Profile
Javier Cote-Sierra has founded Allianthera Suzhou Biopharmaceutical Co Ltd in 2020, where he currently holds the position of Director & Chief Scientific Officer.
He previously worked at Pfizer Inc. as Senior Director-External Research & Development from 2015 to 2017, at Genzyme Corp.
as Head-Inflammation & Immunology External Innovation from 2018 to 2020, and will be Chief Scientific Officer at Zura Bio Ltd.
in 2023.
He also served as an Independent Director at JATT Acquisition Corp.
Dr. Cote-Sierra received his graduate and doctorate degrees from Université Libre de Bruxelles.
Javier Cote-Sierra active positions
| Companies | Position | Start |
|---|---|---|
| Allianthera Suzhou Biopharmaceutical Co Ltd | Founder | 2020-11-30 |
Former positions of Javier Cote-Sierra
| Companies | Position | End |
|---|---|---|
| ZURA BIO LIMITED | Chief Tech/Sci/R&D Officer | 2023-04-13 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2019-12-31 |
| PFIZER, INC. | Corporate Officer/Principal | 2016-12-31 |
| JATT ACQUISITION CORP | Director/Board Member | - |
Training of Javier Cote-Sierra
| Université Libre de Bruxelles | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ZURA BIO LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
JATT Acquisition Corp.
 JATT Acquisition Corp. Financial ConglomeratesFinance JATT Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Someit Sidhu on March 10, 2021 and is headquartered in George Town, Cayman Islands. | Finance |
| Allianthera Suzhou Biopharmaceutical Co Ltd |
- Stock Market
- Insiders
- Javier Cote-Sierra